封面
市場調查報告書
商品編碼
2147366

全球超音波人工智慧收益化重點:取得指導、工作流程、雲端、管治,2024-2035 年

Global Ultrasound AI Monetization Focus: Acquisition Guidance, Workflow, Cloud, and Governance, 2024A-2035E

出版日期: | 出版商: Marketstrat, Inc. | 英文 45 Pages | 訂單完成後即時交付

價格

報告摘要

這份 Marketstrat® 聚焦報告探討了 2024 年至 2035 年間,全球超音波生態系統中超音波人工智慧的包裝、定價、應用和市場佔有率獲取方式。本報告與 Marketstrat 的超音波核心模型一致,檢驗了截至 2026 年 6 月的最新趨勢。我們的觀點是:獲利模式的基礎正在從掃描器功能轉向受控工作流程基礎設施,市場佔有率的獲取越來越依賴包裝和應用策略,而非模型品質。

需要解答的關鍵問題

  • 除了常規軟體收入之外,超音波人工智慧的價值還體現在哪裡?
  • 哪些用例已準備好進行大規模商業化,哪些用例仍需要概念驗證?
  • 從實際經濟效益來看,按測試收費、訂閱、捆綁和混合使用協議有何不同?
  • 2025-2026 年的程式設計和支付方式變更帶來了哪些改變?

市場概覽

本報告區分了核心人工智慧經常性收入(包含在生態系統總收入中)和更廣泛的人工智慧價值池(涵蓋硬體整合人工智慧、軟體、服務、雲端或計量收費)。兩者之間的差距在於透過捆綁銷售、升級和基於使用量的收費實現的價值交易。雲端和計量收費成長最快,而軟體仍佔最大佔有率。北美在貨幣化品質方面處於領先地位,而中國雖然部署規模龐大,但經常性收入的經濟效益相對較低。

主要市場趨勢

  • 1. 價值正在從探測轉向其他方面。主機正在成為一個提供指導、自動產生報告和銷售雲端評估的平台。
  • 2. 兌換系統決定了價格的上限。即使功能相同,沒有兌換碼的價格也接近零,而使用兌換碼的價格則會高得多。
  • 3. 支付方式已從假設變為事實。首筆 Echo AI 支付和 CPT 2026 的首個 AI 代碼集群已確定了官方價格。
  • 4. 病例發現比效率更重要。發現那些被忽視的、可計費的疾病,比僅僅追求生產力更能為採購提供永續的合理性。
  • 5. 採用嵌入式解決方案與採用獨立於供應商的解決方案代表著一種結構性分化。那些只提供功能而不提供程式碼或銷售管道的供應商將被市場吞併。

目錄

第1章摘要整理

  • 結論
  • 5個關鍵點

第2章:調查方法

  • 本報告摘要
  • 兩條故意分開的AI路線。
  • 依證和品質保證 (QA) 規則

第3章:超音波人工智慧的收入結構:核心經常性收入與人工智慧橋接器的總收入

  • 市場規模估算
  • 貨幣化差距及其擴大的機制
  • 收入來源機制:為什麼雲端運算佔了主導市場佔有率。
  • 經常性收入來源:功能、細分市場與 ARPU。
  • 生態系背景:溯源探測的價值
  • 區域架構:Bridge 旨在實現盈利的領域(全球範圍,重點關注美國和中國)

第4章:用例機會圖

第5章:商業化準備:ARC 指數

第6章:貨幣化模式與定價的演示

  • 五種商業模式及其各自實際產生的收入
  • 定價階段一目了然
  • 投資報酬率示範:買家實際回饋
  • 選擇適合您使用場景的合約

第7章 贖回機制:閘門變數及2025-2026年的轉折點

  • 為什麼償還至關重要
  • 四條路徑,提升永續性
  • 2025-2026年將發生哪些變化:從理論到支付
  • 言下之意:定價權會隨著階段而改變。

第8章:掃描器原生策略與工作流程原生策略,以及升級與軟體包的分階段部署

  • 決定性的區別
  • 升級及套餐階梯:一款經濟型車型,三種軌道

第9章:競爭格局與控制平面

  • 人工智慧市場並非單一市場,而是五個子市場。
  • 誰實際控制控制平面?
  • 嵌入式與合作夥伴式:過時的OEM模式

第10章:值得關注的公司

  • Ultromics:保險報銷領域的先驅
  • Us2.ai:投資報酬率衡量,獨立於供應商
  • UltraSight:一家專注於提供導引解決方案,以取代嵌入式系統的公司。
  • Caption Health/GE HealthCare:平台整合指南
  • Butterfly Network:結合設備和營運成本 (OpEx) 的概念驗證案例。
  • Echo IQ:以報銷為中心的偵測
  • Exo:專注於工作流程的手持新興企業
  • brightHeart:正在開發中的一種旨在提高產前診斷品質的技術層。
  • Sonio/三星麥迪遜:以OEM規模部署的產前診斷支持
  • Koios Medical:整合於檢查台的專業決策支援系統
  • DiA成像分析/飛利浦:平台整合了定量分析功能
  • AS軟體:報告顯示數位落後的領域
  • 精選列表

第11章:戰略手冊

  • 系統OEM
  • 手持/POCUS平台
  • 人工智慧軟體專業公司
  • 工作流程/報告供應商
  • 醫療服務提供者和綜合醫療網路(IDN)
  • 投資者和策略投資者

第12章:顯著徵兆與總結

  • 未來12-24個月的展望
  • 概要
Product Code: MINTF-02105-UF02

Report Overview

This Marketstrat® Focus Report examines how ultrasound AI is packaged, priced, reimbursed and captured across the global ultrasound ecosystem from 2024 through 2035. It reconciles to Marketstrat's ultrasound core model with developments refreshed through June 2026. Our view: monetization is shifting from scanner features to governed workflow infrastructure, and capture depends more on packaging and reimbursement position than on model quality.

Key Questions Answered

  • Where does ultrasound AI value sit beyond the recurring software line?
  • Which use cases are ready for scaled monetization, and which still need evidence?
  • How do per-study, subscription, bundle and hybrid usage contracts compare on observed economics?
  • What did the 2025–2026 coding and payment changes alter?

Market Snapshot

The report separates core AI recurring revenue, which sits inside ecosystem totals, from a broader AI value-pool bridge spanning hardware-linked AI, software, services and cloud or pay-per-use. The widening gap between them is value that transacts through bundles, upgrades and consumption. Cloud and pay-per-use grows fastest; software stays largest. North America anchors monetization quality, while China offers deployment scale with thinner recurring economics.

Key Market Trends

  • 1. Value is migrating above the probe. The console becomes the platform for selling guidance, reporting automation and cloud review.
  • 2. Reimbursement sets the price ceiling. The same capability prices near zero without a code and at a premium with one.
  • 3. Payment moved from thesis to fact. First echo-AI payments and the first AI code family in CPT 2026 set public prices.
  • 4. Case-finding outsells efficiency. Detecting missed, billable disease builds a more durable purchase case than productivity alone.
  • 5. Embedding versus vendor-agnostic insertion is the structural fork. Feature-only vendors without a code or channel face absorption.

Competitive Structure

Competition is analyzed as five sub-battlegrounds, from guided acquisition to cloud review. The report maps control points, dates OEM moves by GE HealthCare, Philips, Samsung Medison and Siemens Healthineers, and profiles twelve vendors including Ultromics, UltraSight, Butterfly Network, Echo IQ and Koios Medical.

What's Inside

Revenue architecture: AI streams, capabilities, hardware segments and regions, with US and China views.

Markintel® frameworks: Solution Adoption & Growth Matrix, ARC-Index readiness scoring and the Upgrade & Package Ladder.

Pricing and reimbursement: Five commercial archetypes, an observed price ladder and four US payment pathways ranked by durability.

Playbooks and signposts: Six player-specific playbooks and dated signals for the next 12–24 months.

Who Should Read This Report

  • Ultrasound OEM and handheld platform executives
  • AI software founders and product leaders
  • Workflow, reporting and enterprise imaging vendors
  • Health systems and POCUS programs buying at fleet scale
  • Investors and corporate-development teams

Why This Report

This report follows the money. It ties each use case to a buyer, contract form, ROI logic and reimbursement rung, and keeps every modeled figure traceable to one core model, showing which capabilities can carry scaled economics.

Table of Contents

1. EXECUTIVE SUMMARY

  • 1.1 THE BOTTOM LINE
  • 1.2 FIVE TAKEAWAYS

2. SCOPE, DEFINITIONS, AND METHODOLOGY

  • 2.1 WHAT THIS REPORT IS
  • 2.2 TWO AI LINES, DELIBERATELY SEPARATE
  • 2.3 EVIDENCE BASE AND QA RULES

3. ULTRASOUND AI REVENUE ARCHITECTURE: CORE RECURRING VS THE TOTAL AI BRIDGE

  • 3.1 SIZING THE POOL
  • 3.2 THE MONETIZATION GAP AND HOW IT WIDENS
  • 3.3 STREAM MECHANICS: WHY CLOUD WINS MIX
  • 3.4 WHERE THE RECURRING DOLLARS ATTACH: CAPABILITIES, SEGMENTS, AND ARPU
  • 3.5 THE ECOSYSTEM CONTEXT: VALUE MIGRATING ABOVE THE PROBE
  • 3.6 REGIONAL ARCHITECTURE: WHERE THE BRIDGE MONETIZES (GLOBAL, WITH U.S. AND CHINA COLOR)

4. USE-CASE OPPORTUNITY MAP

5. COMMERCIAL READINESS: THE ARC-INDEX

6. MONETIZATION MODELS AND PRICING EVIDENCE

  • 6.1 FIVE COMMERCIAL ARCHETYPES AND WHAT EACH ACTUALLY CLEARS
  • 6.2 THE PRICING LADDER IN ONE VIEW
  • 6.3 ROI EVIDENCE: WHAT BUYERS ACTUALLY REPORT
  • 6.4 MATCHING CONTRACT TO USE CASE

7. REIMBURSEMENT ARCHITECTURE: THE GATING VARIABLE AND THE 2025–2026 INFLECTION

  • 7.1 WHY REIMBURSEMENT GATES EVERYTHING
  • 7.2 FOUR PATHWAYS, ASCENDING DURABILITY
  • 7.3 WHAT CHANGED IN 2025–2026: FROM THEORY TO PAYMENT
  • 7.4 IMPLICATIONS: PRICING POWER FOLLOWS THE RUNG

8. SCANNER-NATIVE VS WORKFLOW-NATIVE STRATEGY AND THE UPGRADE & PACKAGE LADDER

  • 8.1 THE SIGNATURE DISTINCTION
  • 8.2 THE UPGRADE & PACKAGE LADDER: ONE ECONOMICS, THREE TRACKS

9. COMPETITIVE LANDSCAPE AND CONTROL PLANES

  • 9.1 FIVE SUB-BATTLEGROUNDS, NOT ONE AI MARKET
  • 9.2 WHO ACTUALLY HOLDS THE CONTROL PLANES
  • 9.3 EMBED VS PARTNER: THE OEM POSTURES, DATED

10. COMPANY SPOTLIGHTS

  • Ultromics: the reimbursement front-runner
  • Us2.ai: measurement ROI, vendor-agnostic
  • UltraSight: the anti-embed guidance specialist
  • Caption Health / GE HealthCare: guidance as platform glue
  • Butterfly Network: the device-plus-OpEx proof point
  • Echo IQ: reimbursement-oriented detection
  • Exo: workflow-heavy handheld challenger
  • BrightHeart: prenatal quality layer in the making
  • Sonio / Samsung Medison: prenatal decision support, OEM-scaled
  • Koios Medical: specialty decision support goes on-cart
  • DiA Imaging Analysis / Philips: quantification absorbed into the platform
  • AS Software: the under-digitized reporting lane
  • 10.1 WATCH LIST

11. STRATEGIC PLAYBOOKS

  • Systems OEMs
  • Handheld / POCUS platforms
  • AI software specialists
  • Workflow / reporting vendors
  • Providers and IDNs
  • Investors and strategics

12. SIGNALS TO WATCH AND CLOSING SYNTHESIS

  • 12.1 DATED SIGNPOSTS, NEXT 12–24 MONTHS
  • 12.2 CLOSING SYNTHESIS

List of Tables

  • TABLE 1: ULTRASOUND AI MONETIZATION DASHBOARD: EXECUTIVE VIEW
  • TABLE 2: ULTRASOUND AI STREAM DEFINITIONS: WHAT SITS WHERE, AND HOW TO READ IT
  • TABLE 3: ULTRASOUND AI VALUE-POOL BRIDGE BY STREAM: REVENUE, GROWTH, AND MIX
  • TABLE 4: CORE AI RECURRING BY CAPABILITY: SHARE AND REVENUE (2024A VS 2035E)
  • TABLE 5: U.S. AND CHINA AI LAYERS: MODELED VIEW (2024A, 2030E, 2035E)
  • TABLE 6: SOLUTION ADOPTION & GROWTH MATRIX: ULTRASOUND AI / WORKFLOW USE CASES
  • TABLE 7: ARC-INDEX: ULTRASOUND AI CAPABILITY READINESS AND BEST COMMERCIAL MOTION
  • TABLE 8: MONETIZATION-MODEL COMPARISON: OBSERVED ECONOMICS BY ARCHETYPE
  • TABLE 9: ULTRASOUND AI USE-CASE MONETIZATION MAP: BUYER, CONTRACT, KPI, GATING
  • TABLE 10: U.S. REIMBURSEMENT PATHWAYS FOR ULTRASOUND / ECHO AI: MECHANICS AND STRATEGIC READ
  • TABLE 11: THE 2025–2026 REIMBURSEMENT AND POLICY INFLECTION: DATED DEVELOPMENTS AND IMPLICATIONS
  • TABLE 12: SCANNER-NATIVE VS WORKFLOW-NATIVE MONETIZATION: THE SIGNATURE COMPARISON
  • TABLE 13: UPGRADE & PACKAGE LADDER: CONDENSED THREE-TRACK VIEW
  • TABLE 14: AI / WORKFLOW COMPETITIVE BATTLEGROUNDS: ULTRASOUND
  • TABLE 15: VENDOR TRACTION SUMMARY: CONTROL PLANE, MODEL, AND THE 2025–2026 SIGNAL

List of Figures

  • FIGURE 1: WORLD ULTRASOUND AI VALUE-POOL BRIDGE BY STREAM, 2024A–2035E
  • FIGURE 2: CORE AI RECURRING VS TOTAL AI BRIDGE: THE MONETIZATION GAP
  • FIGURE 3: AI BRIDGE MIX SHIFT, 2024A VS 2035E
  • FIGURE 4: VALUE MIGRATION ABOVE THE PROBE: ECOSYSTEM LAYERS AND THE AI BRIDGE SHARE
  • FIGURE 5: AI BRIDGE BY REGION, 2024A VS 2035E
  • FIGURE 6: ARC READINESS VS GROWTH POTENTIAL: SCALED-ECONOMICS MAP
  • FIGURE 7: OBSERVED ULTRASOUND / CARDIAC-AI PRICE POINTS BY COMMERCIAL MODEL
  • FIGURE 8: THE ULTRASOUND-AI REIMBURSEMENT AND CLEARANCE TIMELINE, OCT 2023 – JUN 2026